Nabsys Raises $20M in Private Financing Round | GenomeWeb

NEW YORK (GenomeWeb News) – Nabsys today said that it has raised $20 million in a Series D financing round, which will support the launch of the firm's semiconductor-based single-molecule sequencing platform.

The financing round was led by Bay City Capital, a new investor in the firm, with previous investors Point Judith Capital and Stata Venture Partners also participating.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.